Liang X, Qin Y, Li P, Mo Y, Chen D
Ther Adv Med Oncol. 2025; 17:17588359251321904.
PMID: 40012707
PMC: 11863263.
DOI: 10.1177/17588359251321904.
Miao L, Feng S, Ding B, Zhang K, Ding Y, Shen Y
Int J Womens Health. 2024; 16:1303-1313.
PMID: 39100113
PMC: 11298178.
DOI: 10.2147/IJWH.S469642.
Yan S, Cheng M, Peng W, Liu T, Zhang J, Sheng M
BMC Gastroenterol. 2024; 24(1):35.
PMID: 38229048
PMC: 10790470.
DOI: 10.1186/s12876-024-03133-x.
Goncalves E, Fontes F, Rodrigues J, Calisto R, Bento M, Lunet N
Breast Cancer Res Treat. 2023; 204(2):367-376.
PMID: 38151690
DOI: 10.1007/s10549-023-07224-3.
Sancheti S, Goel A, Singla A, Chauhan K, Arora K, Chaudhary D
J Lab Physicians. 2023; 15(4):524-532.
PMID: 37780887
PMC: 10539055.
DOI: 10.1055/s-0043-1768631.
Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
Song Y, Wang J, Wang X, Li R, Niu X, Yang Y
Transl Cancer Res. 2023; 12(4):939-948.
PMID: 37180649
PMC: 10174759.
DOI: 10.21037/tcr-23-301.
The changes of subtype markers between first and second primary breast cancers.
Li C, Lyu Z, Wang Z, Hao C, Huang Y, Song F
Cancer Med. 2023; 12(12):13649-13660.
PMID: 37096879
PMC: 10315743.
DOI: 10.1002/cam4.5979.
Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.
Lu M, Liu H, Zheng B, Sun S, Chen C
Cancers (Basel). 2022; 14(20).
PMID: 36291901
PMC: 9600751.
DOI: 10.3390/cancers14205117.
Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review.
Ge S, Wang B, Wang Z, He J, Ma X
Front Oncol. 2022; 12:840431.
PMID: 35756608
PMC: 9213651.
DOI: 10.3389/fonc.2022.840431.
Application of a Novel Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients.
Miao H, Sun Y, Jin Y, Hu X, Song S, Zhang J
Front Oncol. 2022; 12:894767.
PMID: 35712499
PMC: 9195516.
DOI: 10.3389/fonc.2022.894767.
Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.
Hussain Z, Khan J, Saeed A, Dihowm F
Cancer Diagn Progn. 2022; 1(5):393-398.
PMID: 35403153
PMC: 8962871.
DOI: 10.21873/cdp.10052.
Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study.
Lin X, Lin X, Li Y, Zhang Y, Lin J, Zhang G
Int J Gen Med. 2021; 14:8775-8784.
PMID: 34853531
PMC: 8627860.
DOI: 10.2147/IJGM.S338455.
Genetic alterations associated with multiple primary malignancies.
Nyqvist J, Kovacs A, Einbeigi Z, Karlsson P, Forssell-Aronsson E, Helou K
Cancer Med. 2021; 10(13):4465-4477.
PMID: 34057285
PMC: 8267160.
DOI: 10.1002/cam4.3975.
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers.
Girolimetti G, Marchio L, De Leo A, Mangiarelli M, Amato L, Zanotti S
J Cancer Res Clin Oncol. 2020; 147(2):507-516.
PMID: 33236215
PMC: 7817585.
DOI: 10.1007/s00432-020-03459-5.
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers.
Maxwell K, Wenz B, Kulkarni A, Wubbenhorst B, DAndrea K, Weathers B
JCO Precis Oncol. 2020; 4.
PMID: 32954205
PMC: 7496037.
DOI: 10.1200/PO.19.00301.
Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study.
Adelborg K, Farkas D, Sundboll J, Schapira L, Tamang S, Cullen M
BMJ Open Gastroenterol. 2020; 7(1).
PMID: 32611556
PMC: 7328750.
DOI: 10.1136/bmjgast-2020-000413.
Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer.
Li D, Weng S, Zhong C, Tang X, Zhu N, Cheng Y
Front Oncol. 2020; 9:1426.
PMID: 31998630
PMC: 6970432.
DOI: 10.3389/fonc.2019.01426.
Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S, Yang J, Shen Y, Zhao X, Zhang L, Wang B
BMC Public Health. 2019; 19(1):1592.
PMID: 31783815
PMC: 6884836.
DOI: 10.1186/s12889-019-7947-y.
Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep. 2019; 39(6).
PMID: 31138756
PMC: 6566465.
DOI: 10.1042/BSR20181968.
Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K, He X, Yu L, Ni C, Chen H, Guan D
PLoS One. 2019; 14(5):e0215948.
PMID: 31042767
PMC: 6493754.
DOI: 10.1371/journal.pone.0215948.